Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sangamo Therapeutics (SGMO) Cash from Operations (2016 - 2025)

Sangamo Therapeutics (SGMO) has disclosed Cash from Operations for 16 consecutive years, with 24403000.0 as the latest value for Q4 2025.

  • For Q4 2025, Cash from Operations fell 628.23% year-over-year to 24403000.0; the TTM value through Dec 2025 reached 97208000.0, down 44.79%, while the annual FY2025 figure was 97208000.0, 44.79% down from the prior year.
  • Cash from Operations hit 24403000.0 in Q4 2025 for Sangamo Therapeutics, up from 28498000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 11759000.0 in Q3 2024 and bottomed at 68550000.0 in Q1 2021.
  • Average Cash from Operations over 5 years is 42303350.0, with a median of 51552500.0 recorded in 2021.
  • Year-over-year, Cash from Operations crashed 1127.33% in 2021 and then surged 124.86% in 2024.
  • Sangamo Therapeutics' Cash from Operations stood at 52714000.0 in 2021, then fell by 8.22% to 57049000.0 in 2022, then increased by 11.41% to 50538000.0 in 2023, then surged by 93.37% to 3351000.0 in 2024, then plummeted by 628.23% to 24403000.0 in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 24403000.0, 28498000.0, and 18158000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.